fashion -WSS

fashion

author：fashion 2025-09-30 16:24:20 - browse：17335

Two people run on the sugar-phosphate backbone of DNA while holding base pairs — in the lab coverage from STAT — Adobe

LONDON — Widespread genetic testing as well as the development of cutting-edge, customized genetic therapies have opened the door to treating many more inherited conditions than previously possible. A few recent cases, in which bespoke medicines were created for children with exceedingly rare mutations, have raised hopes for furthering the approach.

Now, researchers and government agencies in the U.K. are trying to figure out the nitty-gritty to replicate those early one-off successes for as many patients as possible — what sort of preclinical testing a tailor-made treatment needs to go through before being used, what regulatory thresholds each treatment needs to clear, and how to pay for these therapies.

“A lot of the barriers are no longer scientific — we can make these drugs,” said Matthew Wood, a professor of pediatrics at the University of Oxford. “It’s more about, can we make them at a cost that is reasonable enough? And can we get the regulators to reduce the barriers to doing this so that when a patient shows up, you can actually make a drug quickly enough to benefit that patient, rather than it costing huge amounts of money and taking two or three years to do it?”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Biogen’s boardroom scandal saddles CEO with first crisis

explore

WSS

YouTube cracks down on misinformation on cancer treatment

Hospitals are dialing back on venture capital investing

Beware reading your test results before your doctor does

Indictment alleges Trump's ex

Prescription digital therapeutics are key to pharma’s future

Vertex cell therapy lets patients with type 1 diabetes stop insulin

leisure time

fashion

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

YouTube cracks down on misinformation on cancer treatment

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Illumina slashes 2023 revenue projections yet again

The high cost of giving birth even with insurance

What to know about the judge who will handle the Trump case

Continuity nursing helped my family in our darkest PICU moments

Crowdfunding for unproven stem cell procedures spreads misinformation

After affirmative action ruling, medical educators look to 'holistic review'

Lupron, used to halt puberty in children, may cause lasting health problems

knowledge

Drug cartel violence flares in western Mexico after vigilante leader's killing

Health AI: on the border between health care and tech

The biotech scorecard for Q3: 15 stock

Being 'nonadherent' patient made me a more empathetic doctor

The wait for US passports is creating travel purgatory and snarling summer plans

The biotech scorecard for Q3: 15 stock

leisure time

explore

explore

focus